13 companies

CCC

Market Cap: zł10.7b

Engages in the retail sale of footwear and other products in Poland, Central and Eastern Europe, and Western Europe.

CCC

zł138.70

7D

-2.3%

1Y

-31.3%

Wirtualna Polska Holding

Market Cap: zł1.6b

Through its subsidiaries, engages in the media, advertising, and e-commerce businesses in Poland.

WPL

zł53.60

7D

-2.9%

1Y

-31.6%

ZE PAK

Market Cap: zł1.1b

Produces and sells electricity and heat in Poland.

ZEP

zł22.10

7D

0.5%

1Y

41.8%

Ryvu Therapeutics

Market Cap: zł453.4m

A clinical-stage drug discovery and development company, engages in developing of small molecule therapies for treatment in oncology in Poland, European Union, and internationally.

RVU

zł24.70

7D

7.6%

1Y

-45.6%

Erbud

Market Cap: zł328.1m

Engages in the construction business in Poland and internationally.

ERB

zł27.50

7D

-3.0%

1Y

-16.2%

Captor Therapeutics Spolka Akcyjna

Market Cap: zł260.4m

A biopharmaceutical company, focuses on the discovery and development of protein degradation drugs for cancer and autoimmune diseases.

CTX

zł47.10

7D

4.7%

1Y

-14.7%

Makarony Polskie

Market Cap: zł250.7m

Engages in the manufacture and sale of pastas for various consumers in Poland.

MAK

zł23.00

7D

1.8%

1Y

14.4%

Grupa Kapitalowa IMMOBILE

Market Cap: zł233.8m

Operates in industry, construction, automation and power engineering, hospitality, and development industries in Poland and internationally.

GKI

zł3.12

7D

2.6%

1Y

64.2%

Artifex Mundi

Market Cap: zł161.2m

Develops and publishes computer games worldwide.

ART

zł13.50

7D

1.7%

1Y

-18.7%

NOCTILUCA SPÓLKA AKCYJNA

Market Cap: zł148.6m

Develops, produces, and sells OLED emitter material chemical compounds.

NCL

zł95.40

7D

1.5%

1Y

14.9%

PCF Group Spólka Akcyjna

Market Cap: zł132.3m

Engages in the development and production of video games in Poland and internationally.

PCF

zł3.68

7D

-3.2%

1Y

-61.4%

Molecure

Market Cap: zł126.1m

A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for the treatment of neoplastic and inflammatory diseases in Poland.

MOC

zł6.12

7D

0%

1Y

-32.7%

Poltreg

Market Cap: zł118.0m

A biotechnology company, researches and develops therapies for autoimmune diseases.

PTG

zł25.30

7D

2.0%

1Y

-47.9%